Drake & Associates, LLC

CIK 0001935795 · WAUKESHA, WI · Quarter end: 2026-06-30 · Filed on: 2026-08-10 · Open the SEC source

Drake & Associates, LLC reported 108 positions worth $593.7M as of June 30, 2026 (13F filed August 10, 2026). Largest holding: RECS (9.1%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$593.7M
2026 Q2
Positions
108
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
71.4%
Est. Net Flow (Q)
2026 Q2
10 / 108 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1RECSCOLUMBIA ETF TR ISH$54.2M9.13%1,252,310
2FBNDFIDELITY MERRIMACK STR TRSH$50.0M8.42%1,098,394
3PVALPUTNAM ETF TRUSTSH$48.6M8.19%954,581
4SPYGSPDR SERIES TRUSTSH$45.0M7.59%378,474
5IJHISHARES TRSH$44.3M7.46%574,352
6ACWIISHARES TRSH$43.4M7.31%276,605
7JAAAJANUS DETROIT STR TRSH$38.6M6.50%764,333
8AFIFHORIZON FDSSH$36.4M6.12%3,865,267
9IDMOINVESCO EXCH TRADED FD TR IISH$36.1M6.08%598,229
10PYLDPIMCO ETF TRSH$27.5M4.63%1,036,295

The free plan shows the top 10 positions. The remaining 98 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Drake & Associates, LLC hold as of Q2 2026?

Drake & Associates, LLC reported 108 positions worth $593.7M in its Q2 2026 13F filing. Largest positions: RECS (9.1%), FBND (8.4%), PVAL (8.2%), SPYG (7.6%) and IJH (7.5%).

What did Drake & Associates, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Drake & Associates, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.